Efficacy and safety of topical 0.1% cannabidiol for managing recurrent aphthous ulcers: a randomized controlled trial

BACKGROUND: Although topical steroids constitute the first-line therapy for recurrent aphthous ulcers (RAUs), their long-term use often leads to candidiasis. Although cannabidiol (CBD) can be an alternative for pharmacologically managing RAUs due to its analgesic and anti-inflammatory in vivo effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Umpreecha, Chalapinyo, Bhalang, Kanokporn, Charnvanich, Dusadee, Luckanagul, Jittima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9940329/
https://www.ncbi.nlm.nih.gov/pubmed/36803360
http://dx.doi.org/10.1186/s12906-023-03886-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9940329/
https://www.ncbi.nlm.nih.gov/pubmed/36803360
http://dx.doi.org/10.1186/s12906-023-03886-0

Ejemplares similares